Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Haematologica
|
March 26, 1999
Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion
F España, P Villa, Y Mira, et al.
American Journal of Obstetrics and Gynecology
|
December 1, 1995
The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status
J Gilabert, A Estellés, A Cano, et al.
Thrombosis and Haemostasis
|
May 15, 1998
Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia
A Estellés, J Gilabert, S Grancha, et al.
The Journal of Prevention of Alzheimer'S Disease
|
February 14, 2019
Cross-Sectional Characterization of Albumin Glycation State in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients
M Costa, A Mestre, R Horrillo, et al.
The American Journal of Pathology
|
October 1, 1996
Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease
A Estellés, S Grancha, J Gilabert, et al.
Thrombosis and Haemostasis
|
May 11, 1999
Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease
S Grancha, A Estellés, G Tormo, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1994
Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation
J Gilabert, A Estellés, M J Ayuso, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 1, 2012
Kinetics of the interaction between anti-FVIII antibodies and FVIII from therapeutic concentrates, with and without von Willebrand factor, assessed by surface plasmon resonance
S Grancha, A M Ortiz, C Marañón, et al.
British Journal of Haematology
|
November 25, 2000
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects
R Seguí, A Estellés, Y Mira, et al.
Blood
|
July 1, 1994
Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation
A Estellés, J Gilabert, M Keeton, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Haematologica
|
March 26, 1999
Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion
F España, P Villa, Y Mira, et al.
American Journal of Obstetrics and Gynecology
|
December 1, 1995
The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status
J Gilabert, A Estellés, A Cano, et al.
Thrombosis and Haemostasis
|
May 15, 1998
Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia
A Estellés, J Gilabert, S Grancha, et al.
The Journal of Prevention of Alzheimer'S Disease
|
February 14, 2019
Cross-Sectional Characterization of Albumin Glycation State in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients
M Costa, A Mestre, R Horrillo, et al.
The American Journal of Pathology
|
October 1, 1996
Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease
A Estellés, S Grancha, J Gilabert, et al.
Thrombosis and Haemostasis
|
May 11, 1999
Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease
S Grancha, A Estellés, G Tormo, et al.
Gynecologic and Obstetric Investigation
|
January 1, 1994
Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation
J Gilabert, A Estellés, M J Ayuso, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 1, 2012
Kinetics of the interaction between anti-FVIII antibodies and FVIII from therapeutic concentrates, with and without von Willebrand factor, assessed by surface plasmon resonance
S Grancha, A M Ortiz, C Marañón, et al.
British Journal of Haematology
|
November 25, 2000
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects
R Seguí, A Estellés, Y Mira, et al.
Blood
|
July 1, 1994
Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation
A Estellés, J Gilabert, M Keeton, et al.
Page
of 2